The laboratory supplies market in Italy is expected to reach a projected revenue of US$ 2,954.6 million by 2030. A compound annual growth rate of 8.1% is expected of Italy laboratory supplies market from 2024 to 2030.
In terms of revenue, Italy accounted for 4.1% of the global laboratory supplies market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Europe, Germany laboratory supplies market is projected to lead the regional market in terms of revenue in 2030.
UK is the fastest growing regional market in Europe and is projected to reach USD 4,548.6 million by 2030.
Approximately 800 companies are operating in pharmaceutical and biotechnology industries in Italy, accounting for nearly 7% of the total global R&D investments. High R&D investments are anticipated to fuel the market growth. Italy was the first and one of the worse hit European nations by the COVID-19 pandemic.
According to WHO, as of 19th July 2020, nearly 244,216 confirmed cases of COVID-19 and approximately 35,042 deaths were reported in the country, indicating high prevalence and mortality rate of the disease. This is anticipated to promote research activities to combat the disease, thereby indirectly boosting the market growth.
Furthermore, several clinical trials being conducted in the country are anticipated to increase the demand for clinical laboratory services and products. Some of the stakeholders conducting COVID-19 related trials in the country are Novartis Pharma AG, Alexion Pharmaceuticals, Inc., Rev Immune, Gilead Sciences, Inc., WHO, Imperial College London, AstraZeneca, and Hoffmann-La Roche.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Laboratory Supplies Market Outlook will help companies and investors design strategic landscapes.
Equipment was the largest segment with a revenue share of 64.07% in 2023.
Horizon Databook has segmented the Italy laboratory supplies market based on equipment, disposables covering the revenue growth of each sub-segment from 2018 to 2030.
Approximately 800 companies are operating in pharmaceutical and biotechnology industries in Italy, accounting for nearly 7% of the total global R&D investments. High R&D investments are anticipated to fuel the market growth. Italy was the first and one of the worse hit European nations by the COVID-19 pandemic.
According to WHO, as of 19th July 2020, nearly 244,216 confirmed cases of COVID-19 and approximately 35,042 deaths were reported in the country, indicating high prevalence and mortality rate of the disease. This is anticipated to promote research activities to combat the disease, thereby indirectly boosting the market growth.
Furthermore, several clinical trials being conducted in the country are anticipated to increase the demand for clinical laboratory services and products. Some of the stakeholders conducting COVID-19 related trials in the country are Novartis Pharma AG, Alexion Pharmaceuticals, Inc., Rev Immune, Gilead Sciences, Inc., WHO, Imperial College London, AstraZeneca, and Hoffmann-La Roche.
Italy Laboratory Supplies Market Product Outlook (Revenue, USD Million , 2018-2030)
Equipment
Disposables
Reasons to subscribe to Laboratory Supplies Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Laboratory Supplies Market Outlook databook
Our clientele includes a mix of Laboratory Supplies Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy Laboratory Supplies Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Italy Laboratory Supplies Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.